Regularly monitor liver function tests (LFTs), including ALT and AST, every 3 months during treatment. Significant elevations warrant dose reduction or discontinuation.
Assess renal function with serum creatinine levels at baseline and periodically thereafter, adjusting dosage for impaired renal function as needed. Consult prescribing guidelines for specific adjustments based on estimated glomerular filtration rate (eGFR).
Carefully observe for photosensitivity reactions; advise patients to use broad-spectrum sunscreen with SPF 30 or higher and protective clothing when exposed to sunlight. If a reaction occurs, immediately discontinue doxycycline and discuss alternative treatment options with the physician.
Monitor for gastrointestinal side effects such as nausea, vomiting, or diarrhea. Mild symptoms may be managed with supportive care, including dietary modifications. Severe symptoms require immediate medical attention and potentially treatment interruption.
Regularly evaluate disease activity using standardized lupus activity indices such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or British Isles Lupus Assessment Group (BILAG) index. This helps determine treatment efficacy and the need for adjustments.
Note: Doxycycline is generally well-tolerated, but individual responses vary. Close collaboration between patient and physician is key to optimizing treatment and managing potential adverse effects. This information is for guidance only and should not replace professional medical advice. Always consult your physician for specific recommendations.
